The ESCEO-IOF Herbert Fleisch Medal, awarded annually by the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF), has been presented to Professor Roger Fielding, Associate Director of the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, USA. The Medal is named in honour of the late Professor Fleisch, a pioneer in the bone and muscle field and is awarded in recognition of outstanding and ground-breaking achievements in basic bone science or musculoskeletal research. It was presented at the opening ceremony of the virtual World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO 2021), taking place from August 26 to 28, 2021.

Professor Cyrus Cooper, IOF President, stated:

 “We are delighted to present this year’s prestigious ESCEO-IOF Medal of Achievement to Professor Roger Fielding, who is a thought-leader in the area of muscle physiology. He has made noteworthy contributions to our understanding of the underlying mechanisms contributing to age-associated decline in skeletal muscle mass, the resultant impact on function, and the role of physical activity, nutrition and specific therapies on attenuating this process in older and frail adults.” 

Roger A. Fielding, Ph.D. is Associate Director of the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University and serves as Director and Senior Scientist of the Nutrition, Exercise Physiology, and Sarcopenia (NEPS) Laboratory. He is also Professor of Nutrition at the Friedman School of Nutrition Science and Policy, Professor of Medicine at Tufts University School of Medicine and the Associate Director of the Boston Claude D. Pepper Older Americans Independence Center. Dr. Fielding is an internationally known researcher who studies the underlying mechanisms contributing to the age-associated decline in skeletal muscle mass, the resultant impact on function, and the potential role of exercise, nutrition, physical activity and other therapies on attenuating this process. He has published over 250 peer-reviewed papers (H-index 98). He has a strong record of extramural funding including support from the NIH, USDA, foundations and industry. Dr. Fielding is an associate editor of the Journals of Gerontology Medical Sciences, and Calcified Tissues International and Musculoskeletal Research.  He has also served as a reviewer on numerous NIH study sections and was elected to the NIH/CSR College of Reviewers. In 2015, he received the Olof Johnell Science Award from the International Osteoporosis Foundation.

###

About the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO)
Held jointly by IOF and ESCEO, the WCO-IOF-ESCEO annual congress is the world’s largest forum for the presentation of clinical research and new advances in the prevention and management of musculoskeletal disorders, including sarcopenia and frailty. WCO-IOF-ESCEO 2021 will be held as a virtual congress from August 26 to 28, 2021, with access on demand for registrants up to three months following the congress. For complete information visit http://virtual.wco-iof-esceo.org/  #OsteoCongress

About IOF
The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as 268 patient, medical and research societies, work together to make fracture prevention and healthy mobility a worldwide heath care priority. https://www.osteoporosis.foundation  @iofbonehealth

About ESCEO
The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. www.esceo.org